Bionovo Inc: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile

Antisoma is a development stage biotechnology company focused on the development of novel anticancer drugs. The Company has built a diversified product pipeline based on in-licensing and acquisitions that target a variety of tumors by different mechani

TomoTherapy Incorporated: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile

High impact company profile available at BioMarket

Novacea is a development stage biopharmaceutical company engaged in in-licensing, developing and commercializing of novel therapies for the treatment of diseases in the therapeutic area of oncology. The company’s lead candidate, Ascenter, is a Ph

High impact company profile available at BioMarket

Poniard Pharmaceuticals, formerly known as NeoRx Corporation, is a biopharmaceutical company focused on the discovery, development and commercialization of cancer therapy products. The company’s lead product candidate, Picoplatin, is currently in

High impact company profile available at BioMarket

TorreyPines Therapeutics is a San-Diego-based biotechnology company formed through a reverse-merger with publicly-held Axonyx in October 2006. Previously known as Neurogenetics, TorreyPines is focused on the discovery and development of novel drug cand

Edwards Lifesciences Corp: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile

High impact company profile available at BioMarket

MannKind, a development-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic products for metabolical disorder and cancer. Technosphere Insulin (TI) System is the company’s lead product candidate in Pha

Hologic Inc: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile

High impact company profile available at BioMarket

High impact company profile available at BioMarket

Javelin Pharmaceuticals is a late development stage specialty pharmaceutical company that discovers, develops and commercializes drugs and improved formulations of existing drugs that target pain management market.

Noven Pharmaceuticals Inc: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile

High impact company profile available at BioMarket

AspenBio Pharma Inc: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile

Boston Scientific is one of the leading companies in less-invasive medical devices market offering more than 15,000 products in over 45 countries across the world under the four core business groups: cardiovascular, endosurgery, neuromodulation and car

Targanta Therapeutics Corporation: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile

High impact company profile available at BioMarket

Threshold Pharmaceuticals is a biotechnology company focused on the discovery, development and commercialization of drugs based on metabolic targeting, an approach that targets fundamental differences in metabolism between normal and certain diseased c

Cadence Pharmaceuticals Inc: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile

High impact company profile available at BioMarket

Vital Signs Inc: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile

High impact company profile available at BioMarket

Smith & Nephew is a diversified medical technology group specializing in orthopaedic reconstruction, orthopaedic trauma and clinical therapies, endoscopy and advanced wound management products. The group acquired two companies, Plus Orthopedics and

High impact company profile available at BioMarket

High impact company profile available at BioMarket